middle.news
Why Is Australian Clinical Labs Buying Back 10% of Its Shares?
8:32am on Thursday 23rd of October, 2025 AEDT
•
Healthcare
Read Story
Why Is Australian Clinical Labs Buying Back 10% of Its Shares?
8:32am on Thursday 23rd of October, 2025 AEDT
Key Points
12-month on-market buy-back of up to 19.5 million shares
Represents approximately 10% of outstanding share capital
No shareholder approval required under 10/12 Corporations Act rule
Buy-back timing and volume subject to market conditions
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Australian Clinical Labs (ASX:ACL)
OPEN ARTICLE